Brief: Calithera Biosciences Reports Fourth Quarter And Full Year 2021 Financial Results And Recent Highlights
March 31 (Reuters) - Calithera Biosciences Inc CALA.O :
* CALITHERA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND RECENT HIGHLIGHTS
* EXPECTS CASH AND CASH EQUIVALENTS TO MEET OPERATING PLAN
THROUGH
Q2 OF 2023
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.92
* Q4 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6qZRqk
Further company coverage: CALA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calithera Biosciences
See all newsBrief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Receives Notice Of Delisting Or Failure From Nasdaq
Calithera slumps as board approves company liquidation and dissolution
Brief: Calithera Biosciences Announces Board Approval Of Complete Liquidation And Dissolution